Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Thalis Papapostolou, Despina D. Briana, Maria Boutsikou, Christos Iavazzo, Karl-Phillip Puchner, Dimitrios Gourgiotis, Antonios Marmarinos & Ariadne Malamitsi-Puchner. (2013) Midtrimester amniotic fluid concentrations of angiogenic factors in relation to maternal, gestational and neonatal characteristics in normal pregnancies. The Journal of Maternal-Fetal & Neonatal Medicine 26:1, pages 75-78.
Read now
Read now
Articles from other publishers (27)
Ele Hanson, Kristiina Rull, Kaspar Ratnik, Pille Vaas, Pille Teesalu & Maris Laan. (2022) Value of soluble fms-like tyrosine kinase-1/placental growth factor test in third trimester of pregnancy for predicting preeclampsia in asymptomatic women. Journal of Perinatal Medicine 50:7, pages 939-946.
Crossref
Crossref
Victoria Higgins, Liyan Ma, Bonny Lem Ragosnig, Nir Melamed, Michelle Hladunewich, Tim James, Joao Leite, Mary Rozmanc, Jon Barrett, Arthur Zaltz, Paul M Yip & Lei Fu. (2022) Analytical Performance and Quality Indicators of Fully Automated Immunoassays for sFlt-1 and PlGF. The Journal of Applied Laboratory Medicine 7:2, pages 555-567.
Crossref
Crossref
Angela Wing To Sin, Liona C. Poon, Piya Chaemsaithong, Yi Man Isabella Wah, Shuk Yi Annie Hui, Yuen Ha Ting, Kwok Ming Law, Tak Yeung Leung & Daljit Singh Sahota. (2021) Impact of replacing or adding placental growth factor on Down syndrome screening: A prospective cohort study. Prenatal Diagnosis 41:9, pages 1111-1117.
Crossref
Crossref
Birgitte Mitlid-Mork, Sophie Bowe, Jon M. Gran, Nils Bolstad, Jens Petter Berg, Christopher W. Redman, Anne Cathrine Staff & Meryam Sugulle. (2020) Maternal placental growth factor and soluble fms-like tyrosine kinase-1 reference ranges in post-term pregnancies: A prospective observational study. PLOS ONE 15:10, pages e0240473.
Crossref
Crossref
Elisa Simón, Ignacio Herraiz, Cecilia Villalaín, Paula Isabel Gómez-Arriaga, María Soledad Quezada, Elena Ana López-Jiménez & Alberto Galindo. (2020) Correlation of Kryptor and Elecsys® immunoassay sFlt-1/PlGF ratio on early diagnosis of preeclampsia and fetal growth restriction: A case-control study. Pregnancy Hypertension 20, pages 44-49.
Crossref
Crossref
Saskia Rowson, Maya Reddy, Daniel L. Rolnik, Fabricio Da Silva Costa & Kirsten R. Palmer. (2019) Stability of placental growth factor, soluble fms-like tyrosine kinase 1, and soluble fms-like tyrosine kinase 1 e15a in human serum and plasma. Placenta 86, pages 1-3.
Crossref
Crossref
Holger Stepan, Martin Hund, Peter Dilba, Johanna Sillman & Dietmar Schlembach. (2019)
Elecsys
®
and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable?
. Clinical Chemistry and Laboratory Medicine (CCLM) 57:9, pages 1339-1348.
Crossref
Crossref
Yvonne Kwun Yue Cheng, Liona Chiu Yee Poon, Andrew Shennan, Tak Yeung Leung & Daljit Singh Sahota. (2019) Inter-manufacturer comparison of automated immunoassays for the measurement of soluble FMS-like tyrosine kinase-1 and placental growth factor. Pregnancy Hypertension 17, pages 165-171.
Crossref
Crossref
Amélie Boutin, Suzanne Demers, Cédric Gasse, Yves Giguère, Amélie Tétu, Geneviève Laforest & Emmanuel Bujold. (2019) First-Trimester Placental Growth Factor for the Prediction of Preeclampsia in Nulliparous Women: The Great Obstetrical Syndromes Cohort Study. Fetal Diagnosis and Therapy 45:2, pages 69-75.
Crossref
Crossref
Jane E. Whitney, Melanie Silverman, Jackson S. Norton, Richard G. Bachur & Elliot Melendez. (2018) Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor as Novel Biomarkers for Poor Outcomes in Children With Severe Sepsis and Septic Shock. Pediatric Emergency Care Publish Ahead of Print.
Crossref
Crossref
Tuangsit Wataganara, Jarunee Leetheeragul, Suchittra Pongprasobchai, Anuwat Sutantawibul, Chayawat Phatihattakorn & Surasak Angsuwathana. (2018) Prediction and prevention of pre‐eclampsia in Asian subpopulation. Journal of Obstetrics and Gynaecology Research 44:5, pages 813-830.
Crossref
Crossref
YKY Cheng, TY Leung, LW Law, YH Ting, KM Law & DS Sahota. (2018) First trimester screening for pre-eclampsia in Chinese pregnancies: case-control study. BJOG: An International Journal of Obstetrics & Gynaecology 125:4, pages 442-449.
Crossref
Crossref
Ane M. Holme, Marie C.P. Roland, Tore Henriksen & Trond M. Michelsen. (2016) In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies. American Journal of Obstetrics and Gynecology 215:6, pages 782.e1-782.e9.
Crossref
Crossref
Gaea S. Moore, Amanda A. Allshouse, Virginia D. Winn, Henry L. Galan & Kent D. Heyborne. (2015) Baseline placental growth factor levels for the prediction of benefit from early aspirin prophylaxis for preeclampsia prevention. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 5:4, pages 280-286.
Crossref
Crossref
Anna YliniemiKaarin MakikallioTeemu KorpimakiHeikki KouruJaana MarttalaMarkku Ryynanen. (2015) Combination of PAPPA, fhCGβ, AFP, PIGF, sTNFR1, and Maternal Characteristics in Prediction of Early-onset Preeclampsia. Clinical Medicine Insights: Reproductive Health 9, pages CMRH.S21865.
Crossref
Crossref
Tim I. M. Korevaar, Eric A. P. Steegers, Sarah Schalekamp-Timmermans, S. Ligthart, Yolanda B. de Rijke, W. Edward Visser, Willy Visser, Sabine M. P. F. de Muinck Keizer-Schrama, Albert Hofman, Herbert Hooijkaas, Jacoba J. Bongers-Schokking, Henk Russcher, Henning Tiemeier, Vincent W. V. Jaddoe, Theo J. Visser, Marco Medici & Robin P. Peeters. (2014) Soluble Flt1 and Placental Growth Factor Are Novel Determinants of Newborn Thyroid (Dys)Function: The Generation R Study. The Journal of Clinical Endocrinology & Metabolism 99:9, pages E1627-E1634.
Crossref
Crossref
Tinnakorn Chaiworapongsa, Roberto Romero, Steven J. Korzeniewski, Juan Pedro Kusanovic, Eleazar Soto, Jennifer Lam, Zhong Dong, Nandor G. Than, Lami Yeo, Edgar Hernandez-Andrade, Agustín Conde-Agudelo & Sonia S. Hassan. (2013) Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia. American Journal of Obstetrics and Gynecology 208:4, pages 287.e1-287.e15.
Crossref
Crossref
Edith H. van den HoovenFrank H. Pierik, Yvonne de Kluizenaar, Albert HofmanSjoerd W. van Ratingen, Peter Y.J. Zandveld, Henk RusscherJan LindemansHenk M.E. Miedema, Eric A.P. Steegers & Vincent W.V. Jaddoe. (2012) Air Pollution Exposure and Markers of Placental Growth and Function: The Generation R Study. Environmental Health Perspectives 120:12, pages 1753-1759.
Crossref
Crossref
K. O. Kagan, M. Hoopmann, H. Abele, R. Alkier & K. Lüthgens. (2012) First-trimester combined screening for trisomy 21 with different combinations of placental growth factor, free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound in Obstetrics & Gynecology 40:5, pages 530-535.
Crossref
Crossref
S. Theilade, M. Lajer, A. Jorsal, L. Tarnow, H.-H. Parving & P. Rossing. (2012) Arterial stiffness and endothelial dysfunction independently and synergistically predict cardiovascular and renal outcome in patients with type 1 diabetes. Diabetic Medicine 29:8, pages 990-994.
Crossref
Crossref
Samantha Weed, Jamie A. Bastek, Lauren Anton, Michal A. Elovitz, Samuel Parry & Sindhu K. Srinivas. (2012) Examining the correlation between placental and serum placenta growth factor in preeclampsia. American Journal of Obstetrics and Gynecology 207:2, pages 140.e1-140.e6.
Crossref
Crossref
S. Theilade, M. Lajer, A. Jorsal, L. Tarnow, H.‐H. Parving & P. Rossing. (2012) Evaluation of placental growth factor and soluble Fms‐like tyrosine kinase 1 as predictors of all‐cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy. Diabetic Medicine 29:3, pages 337-344.
Crossref
Crossref
N. J. Cowans, M. C. Kisanga & K. Spencer. (2012) Maternal serum placental growth factor in second trimester trisomy 21 pregnancies. Prenatal Diagnosis 32:2, pages 117-121.
Crossref
Crossref
Padmashree Chaudhury WoodhamJulia E. BrittainArthur M. BakerD. Leann LongSina HaeriCarlos A. CamargoJrJrKim A. BoggessAlison M. Stuebe. (2011) Midgestation Maternal Serum 25-Hydroxyvitamin D Level and Soluble Fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio as Predictors of Severe Preeclampsia. Hypertension 58:6, pages 1120-1125.
Crossref
Crossref
N. J. Cowans, H. Alfthan, U. H. Stenman & K. Spencer. (2011) Stability of first trimester placental growth factor in serum and whole blood. Prenatal Diagnosis, pages n/a-n/a.
Crossref
Crossref
N. J. Cowans, A. Stamatopoulou, N. Tørring & K. Spencer. (2011) Early first-trimester maternal serum placental growth factor in trisomy 21 pregnancies. Ultrasound in Obstetrics & Gynecology 37:5, pages 515-519.
Crossref
Crossref
Renée S. Mijal, Claudia B. Holzman, Sarosh Rana, S. Ananth Karumanchi, Jianling Wang & Alla Sikorskii. (2011) Midpregnancy levels of angiogenic markers in relation to maternal characteristics. American Journal of Obstetrics and Gynecology 204:3, pages 244.e1-244.e12.
Crossref
Crossref